You cannot register for this webinar

We are excited to be hosting Tribe Public's Next Webinar Presentation and Q&A Event titled “MPOX 2025: Navigating the Global Public Health Emergency” which will be held Thursday, March 6 (8:30am PT / 11:30 am ET). Our events are efficient and are approximately 30 minutes in duration. GeoVax Labs, Inc.'s (NASDAQ: GOVX) Chief Executive Officer, David Dodd, will deliver a presentation titled “MPOX 2025: Navigating the Global Public Health Emergency” and be available for a 5-10 minute Q&A session at the end of the presentation. So please send in your questions to email: research@tribepublic.com. GeoVax Labs, Inc. (NASDAQ: GOVX) is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. GeoVax has successfully manufactured and released the first clinical drug substance batch of GEO-MVA, its Mpox vaccine candidate, with fill/finish and release of clinical product expected for mid-year, supporting the planned initiation of the clinical evaluation of GEO-MVA in the second half of this year. By registering for this event automatically be joining Tribe Public & be agreeing to receive future FREE invitations for our events. View Disclaimer: https://tribepublic.com/disclaimers.